These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26524883)

  • 1. [[-2] proPSA: A Novel Marker of Prostate Cancer].
    Ishikura K
    Rinsho Byori; 2015 Jan; 63(1):84-93. PubMed ID: 26524883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recent advances in proPSA on early detection in prostate cancer].
    Zhu PY; Hong P; Huang YF
    Zhonghua Nan Ke Xue; 2005 Dec; 11(12):944-6. PubMed ID: 16398372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of proprostate specific antigen for early detection of prostate cancer in men with a total prostate specific antigen range of 4.0 to 10.0 ng/ml.
    Khan MA; Partin AW; Rittenhouse HG; Mikolajczyk SD; Sokoll LJ; Chan DW; Veltri RW
    J Urol; 2003 Sep; 170(3):723-6. PubMed ID: 12913682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next-generation prostate-specific antigen test: precursor form of prostate-specific antigen.
    Ito K; Fujizuka Y; Ishikura K; Cook B
    Int J Clin Oncol; 2014 Oct; 19(5):782-92. PubMed ID: 25135462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-associated forms of prostate specific antigen improve the discrimination of prostate cancer from benign disease.
    Mikolajczyk SD; Rittenhouse HG
    Rinsho Byori; 2004 Mar; 52(3):223-30. PubMed ID: 15137320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum (-5, -7) proPSA for distinguishing stage and grade of prostate cancer.
    Stephan C; Meyer HA; Paul EM; Kristiansen G; Loening SA; Lein M; Jung K
    Anticancer Res; 2007; 27(4A):1833-6. PubMed ID: 17649780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical use of [-2]proPSA (p2PSA) and its derivatives (%p2PSA and Prostate Health Index) for the detection of prostate cancer: a review of the literature.
    Abrate A; Lughezzani G; Gadda GM; Lista G; Kinzikeeva E; Fossati N; Larcher A; Dell'Oglio P; Mistretta F; Buffi N; Guazzoni G; Lazzeri M
    Korean J Urol; 2014 Jul; 55(7):436-45. PubMed ID: 25045441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A (-5, -7) proPSA based artificial neural network to detect prostate cancer.
    Stephan C; Meyer HA; Kwiatkowski M; Recker F; Cammann H; Loening SA; Jung K; Lein M
    Eur Urol; 2006 Nov; 50(5):1014-20. PubMed ID: 16697520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of (-2)proPSA in combination with total PSA and free PSA for the early detection of prostate cancer].
    Lamy PJ; Montels F; Tosi D; Leizour B; Bascoul-Mollevi C; Castan F; Roques S; Nielloud F; Rebillard X
    Ann Biol Clin (Paris); 2013; 71(5):537-44. PubMed ID: 24113439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [proPSA: a precursor of prostate-specific antigen, may improve the early diagnosis of prostate cancer].
    Sela BA; Doolman R
    Harefuah; 2011 May; 150(5):466-9, 489. PubMed ID: 21678645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of proprostate-specific antigen in the diagnosis of prostate cancer.
    Filella X; Alcover J; Molina R; Luque P; Corral JM; Augé JM; Coca F
    Anticancer Res; 2007; 27(1B):607-10. PubMed ID: 17348449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PSA Isoforms' Velocities for Early Diagnosis of Prostate Cancer.
    Heidegger I; Klocker H; Pichler R; Horninger W; Bektic J
    Anticancer Res; 2015 Jun; 35(6):3567-70. PubMed ID: 26026127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From prostate-specific antigen (PSA) to precursor PSA (proPSA) isoforms: a review of the emerging role of proPSAs in the detection and management of early prostate cancer.
    Hori S; Blanchet JS; McLoughlin J
    BJU Int; 2013 Oct; 112(6):717-28. PubMed ID: 22759214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From pro-prostate specific antigen, [-2]pro-prostate specific antigen to Beckman Coulter phi: the evolution of new biomarkers for early detection of prostatic carcinoma.
    Zhang MZ; Lu YP
    Chin Med J (Engl); 2012 May; 125(9):1643-9. PubMed ID: 22800836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative analysis of prostate specific antigen isoforms using immunoprecipitation and stable isotope labeling mass spectrometry.
    Chen YT; Tuan LP; Chen HW; Wei IA; Chou MY; Chen HM; Tyan YC; Chen SF
    Anal Chem; 2015 Jan; 87(1):545-53. PubMed ID: 25427836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proenzyme forms of prostate-specific antigen in serum improve the detection of prostate cancer.
    Mikolajczyk SD; Catalona WJ; Evans CL; Linton HJ; Millar LS; Marker KM; Katir D; Amirkhan A; Rittenhouse HG
    Clin Chem; 2004 Jun; 50(6):1017-25. PubMed ID: 15054080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of the (-2)proPSA and evaluation of the evidence: a systematic review.
    Pecoraro V; Roli L; Plebani M; Trenti T
    Clin Chem Lab Med; 2016 Jul; 54(7):1123-32. PubMed ID: 26609863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pro PSA: a more cancer specific form of prostate specific antigen for the early detection of prostate cancer.
    Mikolajczyk SD; Rittenhouse HG
    Keio J Med; 2003 Jun; 52(2):86-91. PubMed ID: 12862359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical utility of proPSA and "benign" PSA when percent free PSA is less than 15%.
    Khan MA; Sokoll LJ; Chan DW; Mangold LA; Mohr P; Mikolajczyk SD; Linton HJ; Evans CL; Rittenhouse HG; Partin AW
    Urology; 2004 Dec; 64(6):1160-4. PubMed ID: 15596190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of [-2] proPSA and Prostate Health Index (phi) for the detection of prostate cancer: a systematic review and meta-analysis.
    Filella X; Giménez N
    Clin Chem Lab Med; 2013 Apr; 51(4):729-39. PubMed ID: 23154423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.